Business Context and Reporting Period
Company: USANA Health Sciences, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2001
Business Overview: USANA develops and manufactures nutritional, personal care, and weight management products distributed via a network marketing system. As of March 31, 2001, the company had approximately 88,000 Associates and 80,000 Preferred Customers globally. Primary product lines include USANA Nutritionals (66% of sales), LEAN Lifelong (11%), and Sensé (13%).
Key Financial Metrics
| Metric | Q1 2001 (Unaudited) | Q1 2000 (Unaudited) |
|---|---|---|
| Net Sales | $27.6 million | $31.7 million |
| Gross Profit | $19.6 million (71.1% margin) | $24.0 million (75.8% margin) |
| Net Earnings | $0.5 million | $1.4 million |
| Earnings Per Share (Diluted) | $0.05 | $0.13 |
| Operating Cash Flow | $5.3 million | $1.1 million |
| Cash and Equivalents | $2.5 million | $2.4 million (end of period) |
| Total Debt Outstanding | $12.5 million | $12.5 million (approx.) |
| Net Working Capital | $0.3 million | $2.3 million (Dec 30, 2000) |
Debt Structure: $8.0 million on a 5-year term loan and $4.5 million on a revolving line of credit (amended in March 2001 to reduce the line to $12.5 million). Effective interest rate is 6.98%.
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 12.8% ($4.1 million) year-over-year. Drivers included a "value initiative" reducing prices by an average of 24%, a 20% decrease in the Associate base, and weaker foreign currencies.
- Margin Compression: Gross profit margin dropped from 75.8% to 71.1% due to price reductions, currency translation effects, and operating production below capacity to reduce inventory levels.
- Profitability Drop: Net earnings fell 65.4% to $471,000. Net earnings margin declined from 4.3% to 1.7%.
- Customer Base Shift: While the Associate base shrank by 22,000 (20%), the Preferred Customer base grew by 24,000 (42.9%), partially offsetting the distributor decline.
- Foreign Exchange Losses: Foreign currency exchange losses increased significantly to $376,000 from $10,000 in the prior year due to weakening foreign currencies against the U.S. dollar.
Outlook, Risks, and Management Commentary
Capital Expenditures: The company invested $2.7 million in property and equipment in Q1 2001, primarily for expanded warehouse space and improved technology systems. Future spending is estimated at $1.3 million for these projects.
Liquidity: Management believes current cash, the available line of credit, and operating cash flows are sufficient for foreseeable needs. However, additional financing may be required for expansion or adverse conditions, which could result in shareholder dilution.
Key Risks:
- Foreign Currency: Significant exposure to fluctuations in the Canadian, Australian, New Zealand, Hong Kong, Japanese, British, and Euro currencies. No hedging instruments were in place as of March 31, 2001.
- Associate Turnover: High turnover and reliance on the network marketing model pose risks to revenue stability.
- Regulatory: Risks related to government scrutiny of network marketing practices and regulation of nutritional supplements.
- Expansion Costs: SG&A expenses are expected to be pressured in the remainder of 2001 due to costs associated with establishing operations in Japan.
Investor Verification Checklist
- Associate Retention: Verify if the 20% decline in the Associate base stabilizes or continues in subsequent quarters.
- Margin Recovery: Monitor if gross margins can recover as production capacity utilization improves and the impact of the price reduction initiative stabilizes.
- Currency Hedging: Confirm if the company implements hedging strategies to mitigate the $376,000 foreign exchange loss experienced in Q1.
- Japan Expansion: Track the timeline and cost efficiency of the new Japan operations scheduled to open in late 2001.
- Debt Covenants: Ensure continued compliance with financial ratios required by the amended credit facilities.